Clinical Trial: A Phase 3 Trial of the CHIKV VLP Vaccine in Children

U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07003984) titled 'A Phase 3 Trial of the CHIKV VLP Vaccine in Children' on May 27.

Brief Summary: The goal of this multi-center, randomized, double-blind, placebo-controlled study is to evaluate the safety and immunogenicity of CHIKV VLP Vaccine in children 2 to <12 years of age.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Chikungunya Virus

Intervention: BIOLOGICAL: CHIKV VLP vaccine

CHIKV VLP vaccine is comprised of chikungunya virus virus-like particles (CHIKV VLP), adsorbed on aluminum hydroxide (Alhydrogel(R)) adjuvant 2%

BIOLOGICAL: Placebo

Placebo is comprised of formulation buffer

Recruitment Status: NOT_YET_REC...